symbol,statement_type,period_end,line_item,value
THYROCARE.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
THYROCARE.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.376031
THYROCARE.NS,income,2025-03-31 00:00:00,Normalized EBITDA,2037500000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Total Unusual Items,0.0
THYROCARE.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
THYROCARE.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,915100000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,552600000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,1910800000.0
THYROCARE.NS,income,2025-03-31 00:00:00,EBITDA,2037500000.0
THYROCARE.NS,income,2025-03-31 00:00:00,EBIT,1484900000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Net Interest Income,-30500000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Interest Expense,30500000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Interest Income,
THYROCARE.NS,income,2025-03-31 00:00:00,Normalized Income,915100000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,915100000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Total Expenses,5522500000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
THYROCARE.NS,income,2025-03-31 00:00:00,Diluted Average Shares,53577283.0
THYROCARE.NS,income,2025-03-31 00:00:00,Basic Average Shares,53420899.0
THYROCARE.NS,income,2025-03-31 00:00:00,Diluted EPS,17.08
THYROCARE.NS,income,2025-03-31 00:00:00,Basic EPS,17.13
THYROCARE.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,915100000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,915100000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
THYROCARE.NS,income,2025-03-31 00:00:00,Net Income,915100000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Minority Interests,7600000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,907500000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,907500000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Tax Provision,546900000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Pretax Income,1454400000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,148300000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Special Income Charges,0.0
THYROCARE.NS,income,2025-03-31 00:00:00,Other Special Charges,
THYROCARE.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-30500000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
THYROCARE.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,30500000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
THYROCARE.NS,income,2025-03-31 00:00:00,Operating Income,1351000000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Operating Expense,3611700000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Other Operating Expenses,1791400000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,552600000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,552600000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Selling General And Administration,
THYROCARE.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
THYROCARE.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
THYROCARE.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
THYROCARE.NS,income,2025-03-31 00:00:00,Gross Profit,4962700000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Cost Of Revenue,1910800000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Total Revenue,6873500000.0
THYROCARE.NS,income,2025-03-31 00:00:00,Operating Revenue,6873500000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
THYROCARE.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.275995
THYROCARE.NS,income,2024-03-31 00:00:00,Normalized EBITDA,1471900000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Total Unusual Items,0.0
THYROCARE.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
THYROCARE.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,707600000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,470100000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,1667000000.0
THYROCARE.NS,income,2024-03-31 00:00:00,EBITDA,1471900000.0
THYROCARE.NS,income,2024-03-31 00:00:00,EBIT,1001800000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Net Interest Income,-42000000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Interest Expense,42000000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Interest Income,27100000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Normalized Income,707600000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,707600000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Total Expenses,4814600000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,41500000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Diluted Average Shares,52727273.0
THYROCARE.NS,income,2024-03-31 00:00:00,Basic Average Shares,52727273.0
THYROCARE.NS,income,2024-03-31 00:00:00,Diluted EPS,13.42
THYROCARE.NS,income,2024-03-31 00:00:00,Basic EPS,13.42
THYROCARE.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,707600000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,707600000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
THYROCARE.NS,income,2024-03-31 00:00:00,Net Income,707600000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Minority Interests,12700000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,694900000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,694900000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Tax Provision,264900000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Pretax Income,959800000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,93700000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Special Income Charges,0.0
THYROCARE.NS,income,2024-03-31 00:00:00,Other Special Charges,9300000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-42000000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,13300000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,42000000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,27100000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Operating Income,904200000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Operating Expense,3147600000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Other Operating Expenses,1598900000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,470100000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,470100000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Selling General And Administration,656700000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,326600000.0
THYROCARE.NS,income,2024-03-31 00:00:00,General And Administrative Expense,330100000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,41500000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Gross Profit,4051800000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Cost Of Revenue,1667000000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Total Revenue,5718800000.0
THYROCARE.NS,income,2024-03-31 00:00:00,Operating Revenue,5718800000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,15863415.73541
THYROCARE.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.273507
THYROCARE.NS,income,2023-03-31 00:00:00,Normalized EBITDA,1238500000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Total Unusual Items,58000000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,58000000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,644900000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,387100000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,1632300000.0
THYROCARE.NS,income,2023-03-31 00:00:00,EBITDA,1296500000.0
THYROCARE.NS,income,2023-03-31 00:00:00,EBIT,909400000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Net Interest Income,-34500000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Interest Expense,23500000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Interest Income,13800000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Normalized Income,602763415.73541
THYROCARE.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,644900000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Total Expenses,4420500000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,56100000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Diluted Average Shares,53008823.0
THYROCARE.NS,income,2023-03-31 00:00:00,Basic Average Shares,52917822.0
THYROCARE.NS,income,2023-03-31 00:00:00,Diluted EPS,12.14
THYROCARE.NS,income,2023-03-31 00:00:00,Basic EPS,12.16
THYROCARE.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,644900000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,644900000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
THYROCARE.NS,income,2023-03-31 00:00:00,Net Income,644900000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Minority Interests,1300000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,643600000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,643600000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Tax Provision,242300000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Pretax Income,885900000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,4400000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Special Income Charges,4300000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Other Special Charges,-4300000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-34500000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,24800000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,23500000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,13800000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Operating Income,846200000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Operating Expense,2788200000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Other Operating Expenses,848200000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,387100000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,387100000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Selling General And Administration,435300000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,201800000.0
THYROCARE.NS,income,2023-03-31 00:00:00,General And Administrative Expense,233500000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,56100000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Gross Profit,3634400000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Cost Of Revenue,1632300000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Total Revenue,5266700000.0
THYROCARE.NS,income,2023-03-31 00:00:00,Operating Revenue,5266700000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,60567767.43369
THYROCARE.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.226506
THYROCARE.NS,income,2022-03-31 00:00:00,Normalized EBITDA,2372200000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Total Unusual Items,267400000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,267400000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,1761400000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,338700000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,1696900000.0
THYROCARE.NS,income,2022-03-31 00:00:00,EBITDA,2639600000.0
THYROCARE.NS,income,2022-03-31 00:00:00,EBIT,2300900000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Net Interest Income,-25000000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Interest Expense,23700000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Interest Income,7100000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Normalized Income,1554567767.43369
THYROCARE.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,1761400000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Total Expenses,3870000000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,30000000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Diluted Average Shares,52983494.0
THYROCARE.NS,income,2022-03-31 00:00:00,Basic Average Shares,52888361.0
THYROCARE.NS,income,2022-03-31 00:00:00,Diluted EPS,33.25
THYROCARE.NS,income,2022-03-31 00:00:00,Basic EPS,33.3
THYROCARE.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,1761400000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,1761400000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
THYROCARE.NS,income,2022-03-31 00:00:00,Net Income,1761400000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Minority Interests,0.0
THYROCARE.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,1761400000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,1761400000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Tax Provision,515800000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Pretax Income,2277200000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,18000000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Special Income Charges,215200000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Other Special Charges,-215200000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-25000000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,8400000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,23700000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,7100000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Operating Income,2018600000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Operating Expense,2173100000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Other Operating Expenses,798100000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,338700000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,338700000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Selling General And Administration,395000000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,221200000.0
THYROCARE.NS,income,2022-03-31 00:00:00,General And Administrative Expense,173800000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,30000000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Gross Profit,4191700000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Cost Of Revenue,1696900000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Total Revenue,5888600000.0
THYROCARE.NS,income,2022-03-31 00:00:00,Operating Revenue,5888600000.0
THYROCARE.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
THYROCARE.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
THYROCARE.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
THYROCARE.NS,income,2021-03-31 00:00:00,Total Unusual Items,
THYROCARE.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
THYROCARE.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
THYROCARE.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
THYROCARE.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
THYROCARE.NS,income,2021-03-31 00:00:00,EBITDA,
THYROCARE.NS,income,2021-03-31 00:00:00,EBIT,
THYROCARE.NS,income,2021-03-31 00:00:00,Net Interest Income,
THYROCARE.NS,income,2021-03-31 00:00:00,Interest Expense,
THYROCARE.NS,income,2021-03-31 00:00:00,Interest Income,7900000.0
THYROCARE.NS,income,2021-03-31 00:00:00,Normalized Income,
THYROCARE.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
THYROCARE.NS,income,2021-03-31 00:00:00,Total Expenses,
THYROCARE.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,8400000.0
THYROCARE.NS,income,2021-03-31 00:00:00,Diluted Average Shares,
THYROCARE.NS,income,2021-03-31 00:00:00,Basic Average Shares,
THYROCARE.NS,income,2021-03-31 00:00:00,Diluted EPS,
THYROCARE.NS,income,2021-03-31 00:00:00,Basic EPS,
THYROCARE.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
THYROCARE.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
THYROCARE.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
THYROCARE.NS,income,2021-03-31 00:00:00,Net Income,
THYROCARE.NS,income,2021-03-31 00:00:00,Minority Interests,
THYROCARE.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
THYROCARE.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
THYROCARE.NS,income,2021-03-31 00:00:00,Tax Provision,
THYROCARE.NS,income,2021-03-31 00:00:00,Pretax Income,
THYROCARE.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
THYROCARE.NS,income,2021-03-31 00:00:00,Special Income Charges,
THYROCARE.NS,income,2021-03-31 00:00:00,Other Special Charges,-58400000.0
THYROCARE.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
THYROCARE.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,200000.0
THYROCARE.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
THYROCARE.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,7900000.0
THYROCARE.NS,income,2021-03-31 00:00:00,Operating Income,
THYROCARE.NS,income,2021-03-31 00:00:00,Operating Expense,
THYROCARE.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
THYROCARE.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
THYROCARE.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
THYROCARE.NS,income,2021-03-31 00:00:00,Selling General And Administration,372400000.0
THYROCARE.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,238900000.0
THYROCARE.NS,income,2021-03-31 00:00:00,General And Administrative Expense,133500000.0
THYROCARE.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,8400000.0
THYROCARE.NS,income,2021-03-31 00:00:00,Gross Profit,
THYROCARE.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
THYROCARE.NS,income,2021-03-31 00:00:00,Total Revenue,
THYROCARE.NS,income,2021-03-31 00:00:00,Operating Revenue,
